The tobacco giant that makes Marlboro cigarettes has sold a UK inhaler company for a knock-down price due to what it calls an “unwarranted” backlash.Philip Morris International (PMI) has offloaded Vectura Group for £150m ($198m) just three years after buying it in a deal worth more than £1bn.PMI’s decision to buy Vectura, which makes inhalers to treat lung conditions such as asthma, was criticised as being hypocritical.However, PMI defended the move as part of its strategy to away from cigarettes and towards “smoke free” businesses like vaping.
Philip Morris: Marlboro owner sells UK inhaler firm over backlash
Related Posts
EU threatens Apple with fines if it doesn’t open up highly guarded iOS software to rivals
EU antitrust regulators on Thursday warned Apple to throw open its fiercely-guarded proprietary software to rivals — or risk the prospect of major fines from. The European Commission launched so-called specification…
European Union moves to compel Apple to open up operating system to rival tech
The European Union says it will outline steps to compel Apple to open up its iPhone and iPad operating systems to competing technologies under the bloc’s tough new digital rulebook,…